Further analysis found that the three subsets of cDCs (cDC1, cDC2, cDC3) displayed in different abundance between healthy people and patients, cDC1 cells were mainly existed in healthy people, while cDC2 and cDC3 cells were dominantly presented in patents (few differences between DHL and DLBCL groups) and almost absent in healthy people (Fig. 5B). This evidence concerns the gene MPPE1 and diffuse large B-cell lymphoma.